U.S. Markets closed

OHR PHARMACEUTICAL, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors in Ohr Pharmaceutical, Inc.'s Public Offerings To Contact The Firm

NEW YORK, June 4, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, announces that it has been appointed as Lead Counsel in Khanna v. Ohr Pharmaceutical, Inc., et al., No. 1:18-cv-01284-LAP (S.D.N.Y.), a class action alleging violations of the federal securities laws against Ohr Pharmaceutical, Inc. ("Ohr" or the "Company") (OHRP) and certain of the Company's officers and directors.

Faruqi & Faruqi, LLP. (PRNewsfoto/Faruqi & Faruqi, LLP)

If you purchased shares pursuant to Ohr's public offerings on or about (1) April 8, 2014; (2) February 6, 2015; (3) December 8, 2016; and (4) April 5, 2017, and/or you purchased Ohr stock in the open market between April 8, 2014 and January 4, 2018, both dates inclusive, please contact the firm to discuss this matter with us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an email to rgonnello@faruqilaw.com.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Ohr's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Request more information now by clicking here: www.faruqilaw.com/OHRP. There is no cost or obligation to you.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation.  The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation.  The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/faruqilaw or on Facebook at www.facebook.com/FaruqiLaw.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn:  Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

Cision

View original content with multimedia:http://www.prnewswire.com/news-releases/ohr-pharmaceutical-inc-investor-alert-faruqi--faruqi-llp-encourages-investors-in-ohr-pharmaceutical-incs-public-offerings-to-contact-the-firm-300659307.html